Multiple sclerosis (or MS) is a degenerative disease involving the deterioration of nerve cells. MS attacks the central nervous system (CNS), which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, such as numbness in the limbs, or severe, such as paralysis or loss of vision. The progress, severity, and specific symptoms of MS are unpredictable and vary from one person to another.
Multiple sclerosis occurs when the body’s own defense system attacks myelin, the fatty substance that surrounds and protects the nerve fibers in the central nervous system. The nerve fibers themselves can also be damaged. The damaged myelin forms scar tissue (sclerosis), which gives the disease its name. When any part of the myelin sheath or nerve fiber is damaged or destroyed, nerve impulses traveling to and from the brain and spinal cord are distorted or interrupted, producing the variety of symptoms that can occur.
Today, new treatments and advances in research are giving new hope to people affected by the disease. The Multiple Sclerosis Stem Cell Clinical Trials are being studied for their efficacy in improving the complications in patients with MS, through the use of stem cells. These procedures may help patients who don't respond to typical drug treatment.
To learn more about StemGenex clinical trials for Multiple Sclerosis simply fill out the form below and a StemGenex Patient Advocate will contact you shortly.
Fields marked with an asterisk (*) are required.
Question IDs
Object Type Map
Visibility Map
Active Map
Validator Map
Children Map
Parent Map
Question Options Map
Question Options
Question Option Activate Map